New Delhi: The cardiac and anti-diabetes drugs market in India has expanded more than threefold in the past 10 years, data from market research firm Pharmarack suggested. The anti-diabetes market has grown to nearly Rs 17,000 crore from Rs 5,000 crore in 2014, while the cardiac market has expanded to nearly Rs 30,000 crore from Rs 10,000 crore during this period. Innovative medicines , with their premium pricing and better reach, have pushed the market value up, said Sheetal Sapale, vice president, commercial, Pharmarack.
According to the research company's data, there are four brands now with a turnover of at least Rs 200 crore while there were none a decade ago. In the diabetes segment , there are close to 13 brands which have a turnover of Rs 200-400 crore. Finance Financial Literacy i.
e Lets Crack the Billionaire Code By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator View Program Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Mastering Full Stack Development: From Frontend to Backend Excellence By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI for Everyone: Understanding and Applying the Basics on Artificial Intelligence By - Rit.
